Literature DB >> 15696981

Longevity of effects of injectable products for soft-tissue augmentation.

Wm Philip Werschler1, Susan Weinkle.   

Abstract

With the growing number of injectable products for soft-tissue augmentation, non-surgical total facial restoration is within reach. Nevertheless, the ideal injectable product has yet to be developed; at present different approaches are required for different soft-tissue deficits. Products have previously been categorized as either temporary (requiring frequent touch-up treatments) or permanent (associated with possible long-term complications and results that do not co-exist harmoniously with the aging face). Although this dichotomy remains, longer-lasting or "semi-permanent" products are beginning to emerge. There has long been a void in the availability of products that can effectively rejuvenate the face for between 2 and 5 years. This time period would allow the patient to correct the continuing signs of aging with re-treatment at intervals that are tolerable from both a financial and time-management perspective.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15696981

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  2 in total

1.  Treating cutaneous aging with patented technologies.

Authors:  Wing-Fu Lai; Marie C Lin
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

2.  The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate.

Authors:  John K Jackson; Jinying Zhao; Wesley Wong; Helen M Burt
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.